Psych Meds and Premature Delivery
This study examined the associations among maternal depression, measured in several ways, psychiatric medication use in pregnancy, and preterm delivery (PTD).
Data were collected from 3,019 women enrolled in the Pregnancy Outcomes and Community Health Study (1998–2004), a prospective study of pregnant women in five Michigan communities. Information on depressive symptoms, history of depression, and psychiatric medication use was ascertained through interviews at mid-pregnancy. These variables and other relevant covariates were incorporated into regression models with a binary outcome, that is, term (≥37 weeks' gestation) as referent and PTD (<37 weeks' gestation). A second set of models used a multicategory outcome, namely, term as the referent and PTD further subdivided by gestational weeks and clinical circumstances.
The odds of overall PTD was increased among women who used psychiatric medication during pregnancy and had either elevated levels of depressive symptoms at mid-pregnancy (adjusted odds ratio [AOR], 2.0; 95% confidence interval [CI], 1.1–3.6) or a history of depression before pregnancy (AOR, 1.6; 95% CI, 1.1–2.5). The combination of psychiatric medication use in pregnancy and depression, before pregnancy, or within pregnancy was most strongly linked to a medically indicated delivery before 35 weeks' gestation (AOR, 2.9 and 3.6, respectively).
There are at least two plausible explanations for these findings. First, psychiatric medication use in pregnancy may pose an excess risk of PTD. Second, medication use may be an indicator of depressive symptom severity, which is a direct or indirect (i.e., alters behavior) contributing factor to PTD.
From press release:
The odds triple for premature child delivery pregnant women with a history of depression who used psychiatric medication, according to a new study.
Researchers at the University of Washington, University of Michigan and Michigan State University found that a combination of medication use and depression -- either before or during pregnancy -- was strongly linked to delivery before 35 weeks' gestation.
Amelia Gavin, lead author and UW assistant professor of social work, said the findings highlight the need for carefully planned studies that can clarify associations between depression, psychiatric medications and preterm delivery.
"Women with depression face difficult decisions regarding the benefits and risks of using psychotropic medications in pregnancy," Gavin said. "Therefore, a focus on disentangling medication effects and depression effects on mother and offspring health should be a major clinical priority."
"Medication use may be an indicator of depressive symptom severity, which is a direct or indirect contributing factor to pre-term delivery," added Kristine Siefert, co-author and a Michigan professor of social work.
Most physicians initiated preterm deliveries after the women suffered complications, such as pre-eclampsia, poor fetal growth or acute hemorrhage.
The study examined the associations among maternal depression, psychiatric medication use in pregnancy and preterm delivery among women in five Michigan communities who received prenatal care at one of 52 participating clinics between September 1998 and June 2004These women had to be at least 15 years old, with no history of diabetes, and were 15 to 27 weeks pregnant.
Researchers analyzed responses of nearly 3,020 women who participated in the Michigan-based Pregnancy Outcomes and Community Health Study, which asked about depressive symptoms that occurred within the week of taking the questionnaire. The study also asked about the women's history of depression that required medication, such as tranquilizers or sleeping pills.
Overall, 335 women (11 percent) delivered preterm. Among the women who reported having depression during pregnancy, 75 percent had a history of depression and 62 percent used medication in the first half of pregnancy.
Another finding showed that without medication use, elevated levels of depressive symptoms at midpregnancy and history of depression did not pose an increased risk of preterm delivery.
The study's other researchers include Claudia Holzman, professor of epidemiology at Michigan State, and Yan Tian, a data analyst at Michigan State.
The findings appear in the September/October issue of Women's Health Issues. Funding came from the National Center for Research Resources, the National Institute of Child Health and Human Development, the National Institute of Nursing Research, the March of Dimes Foundation and the Centers for Disease Control and Prevention.
Amelia R. Gavin, Claudia Holzman, Kristine Siefert, Yan Tian
Maternal Depressive Symptoms, Depression, and Psychiatric Medication Use in Relation to Risk of Preterm Delivery
Women's Health Issues
University of Washington, School of Social Work, Seattle, Washington.